Ross Clark

Finance

Show us the money

Why society needs cash

By Ross Clark

Economics

Stop the global tax!

The Biden administration’s ‘multilateralism’ could make ‘America First’ look positively magnanimous 

By Ross Clark

Science & Tech

What should we make of the WHO COVID report?

The report does not even claim to be independent

By Ross Clark

Science & Tech

AstraZeneca vaccine gets a boost from US study

The British shot cuts the risk of developing symptomatic infection by 79 percent

By Ross Clark

Economics

Brace yourselves for ‘Bidenomics’

This administration’s financial philosophy seems to be ‘let’s pour rocket fuel on the flames’

By Ross Clark

Finance

The GameStop surge is just another Ponzi scheme

Some will be able to get out in time, but most won’t

By Ross Clark

Science & Tech

Is this the key to understanding COVID immunity?

A new study examines the behavior of the immune system in the months after COVID exposure

By Ross Clark

Europe

What the Lancet study tells us about the Oxford vaccine

All the participants who received the half dose followed by a full dose were under 55

By Ross Clark

Europe

What we don’t yet know about the Oxford vaccine

If one vaccine provides immunity lasting months and another years, the relative costs of each could shift dramatically

By Ross Clark

Europe

Do some people have hidden immunity against COVID?

Over 50 million cases of COVID-19 have now been recorded globally — and yet only a handful of cases of reinfection have been documented

By Ross Clark

China

What if the virus that causes COVID was man-made?

A new paper looks at the possibility that SARS-CoV-2 was artificially created

By Ross Clark

The Moderna vaccine offers more hope

The company can provisionally claim that their vaccine is 94.5 percent effective

By Ross Clark

COVID-19 is distracting us from another medical emergency

The estimated number of deaths globally from measles climbed to 207,500 in 2019

By Ross Clark

Will the Pfizer vaccine live up to the hype?

Any vaccine that proves partly effective will be welcomed with open arms by a world which largely remains in lockdown or semi-lockdown

By Ross Clark

more writers

Stay informed

Thought-provoking commentary and opinion on politics, books and the arts.

Web-only content Copyright © 2021 The Spectator // Magazine content Copyright © 2021 The Spectator